Technicals for GlaxoSmithKline Pharmaceuticals Limited
The current reading of the BOLL BANDS indicator suggests a neutral stance,...
The current reading of the BOLL BANDS indicator suggests a neutral stance,...
GLAXO's current ratio of 1.79 means the company has enough liquidity to...
The list of all important regulatory filings for GlaxoSmithKline Pharmaceuticals Limited which...
The article discusses how AI technologies are leveraging digital footprints to provide...
An analysis of why European banks continue to report strong profits despite...
A comprehensive analysis of the OECD's warning regarding the systemic risks posed...
Published | Title | Summary |
---|---|---|
2025-01-20 15:40:54 | Board Meeting Intimation | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting... |
2025-01-15 12:39:50 | Board Meeting Intimation | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting... |
2024-07-22 13:05:12 | Board Meeting Intimation | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting... |
2024-05-17 14:11:26 | Record Date | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange that Record date... |
Lists of companies in NSE500 with the best and the worst technicals...
Lists of companies in NSE500 with the best and the worst fundamentals...
List of the latest important filings for NSE500....
Analysts are raising red flags about the $1.7 trillion private credit market,...
An analysis of the professions that are expected to remain resilient in...
An in-depth examination of the factors contributing to the U.S. dollar's multi-year...